Context Therapeutics Announces $100 Million Private Placement
Financing includes new and existing leading healthcare investors
Source: eagletribune.com
Stay updated with breaking news from Avidity Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Financing includes new and existing leading healthcare investors
SAN DIEGO--(BUSINESS WIRE)--Apr 24, 2024--
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Clinical-stage biotechnology company TORL BioTherapeutics has announced the closure of an oversubscribed $158m Series B-2 financing round.
$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,...